
CJC-1295 and CJC-1295 with DAC
CJC-1295 Overview
Type: Synthetic peptide, growth hormone-releasing hormone (GHRH) analog
Purpose: Stimulates the pituitary gland to release growth hormone (GH), which can support muscle growth, fat loss, recovery, and anti-aging effects.
Mechanism of Action CJC-1295 binds to GHRH receptors in the pituitary, signaling the gland to release more GH. This also indirectly increases IGF-1 (insulin-like growth factor-1) levels, which mediates many of GH’s anabolic effects.
Half-Life: 30 minutes – this is relatively short, which means it requires multiple injections per day to maintain stable GH release if not modified.
Administration: Subcutaneous injections (typically in the abdomen or thigh). Dosing protocols vary, but daily or multiple times per week injections are common.
Benefits: Supports lean muscle growth, helps reduce body fat, especially visceral fat, may improve sleep quality and recovery. Anti-aging potential via improved skin elasticity and tissue repair. Can support bone density and joint health
Drawbacks: Short half-life means frequent injections.
Potential side effects: water retention, tingling or numbness, headache, or mild fatigue.
CJC-1295 with DAC (Drug Affinity Complex) Type: Modified version of CJC-1295.
Purpose: Designed for longer-lasting GH release, reducing the need for frequent injections.
​
Mechanism of Action: The DAC modification allows CJC-1295 to bind to albumin in the blood, significantly prolonging its half-life. This allows for sustained GH and IGF-1 release over 6–8 days from a single injection.
Half-Life: 6–8 days (much longer than standard CJC-1295)
Administration: Subcutaneous injections; usually once or twice per week is sufficient due to the extended half-life.
Benefits: All benefits of standard CJC-1295, but more convenient dosing sustained GH and IGF-1 levels without daily injections. Potentially more stable and consistent anabolic and anti-aging effects.
Drawbacks: Because GH levels are elevated for longer periods, there may be higher risk of side effects in sensitive individuals. Less flexible for “pulse” GH therapy approaches.
​
Prolonged exposure; slightly higher risk if sensitive in short, CJC-1295 is better if you want more precise GH pulses and are okay with daily injections. CJC-1295 with DAC is more convenient, maintaining GH and IGF-1 levels for days with fewer injections. Both share similar benefits for muscle growth, fat reduction, and anti-aging, but dosing strategy and monitoring GH levels are key to safety.
CJC-1295 (without DAC)
Typical dose: 100–200 mcg per injection.
Frequency: 1–3 times per day (often morning and before bed to mimic natural GH pulses)
Administration: Subcutaneous injection, usually in the abdomen or thigh
Cycle length: 4–12 weeks is common, followed by a break to avoid desensitization.
Notes: Because of the short half-life (30 min), multiple daily injections give the most consistent GH pulses. Some users split doses for morning and pre-sleep to optimize fat loss and recovery.
CJC-1295 with DAC
Typical dose: 1–2 mg per week. If your a beginner you should start with 500mcgs to see how your body responds.
Frequency: 1–2 injections per week due to the long half-life (6–8 days)
Administration: Subcutaneous injection
Cycle length: 4–12 weeks is common; some users go longer with monitoring
Notes: The sustained GH release reduces the need for daily dosing. Because GH levels remain elevated for days, some prefer to start at lower doses to assess tolerance.
Additional Practical Tips:
1. Injection sites- Rotate injection sites (abdomen, thigh) to avoid tissue irritation.
2. Timing-For non-DAC CJC-1295, morning and bedtime injections mimic natural GH rhythm; DAC form timing is flexible due to sustained release.
3. Stacking-Often paired with peptides like Ipamorelin for synergistic GH stimulation.
4. Monitoring- Periodic IGF-1 or GH blood tests help ensure dosing is effective but safe.
5. Side effects to watch- Water retention, tingling, headaches, or joint pain. Adjust dose if these appear.
​



